Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Tamoxifen|DRUG: Tamoxifen
Sponsor: National Cancer Centre, Singapore
Collaborators: National Medical Research Council (NMRC), Singapore